JP2005511571A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511571A5 JP2005511571A5 JP2003540170A JP2003540170A JP2005511571A5 JP 2005511571 A5 JP2005511571 A5 JP 2005511571A5 JP 2003540170 A JP2003540170 A JP 2003540170A JP 2003540170 A JP2003540170 A JP 2003540170A JP 2005511571 A5 JP2005511571 A5 JP 2005511571A5
- Authority
- JP
- Japan
- Prior art keywords
- piperidino
- dichlorophenyl
- butyl
- piperidin
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103795A SE0103795D0 (sv) | 2001-11-02 | 2001-11-02 | Compounds and method for the treatment of överactive bladder |
| PCT/SE2002/001991 WO2003037889A1 (en) | 2001-11-02 | 2002-11-01 | Compounds and method for the treatment of overactive bladder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005511571A JP2005511571A (ja) | 2005-04-28 |
| JP2005511571A5 true JP2005511571A5 (enExample) | 2006-01-05 |
Family
ID=20285984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003540170A Pending JP2005511571A (ja) | 2001-11-02 | 2002-11-01 | 過活動膀胱の治療のための化合物および方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7368461B2 (enExample) |
| EP (1) | EP1444220B1 (enExample) |
| JP (1) | JP2005511571A (enExample) |
| KR (1) | KR20040053239A (enExample) |
| CN (1) | CN1610676A (enExample) |
| AT (1) | ATE353886T1 (enExample) |
| BR (1) | BR0213832A (enExample) |
| CA (1) | CA2465429A1 (enExample) |
| DE (1) | DE60218203T2 (enExample) |
| ES (1) | ES2282491T3 (enExample) |
| IL (1) | IL161600A0 (enExample) |
| MX (1) | MXPA04004075A (enExample) |
| NO (1) | NO20042138L (enExample) |
| SE (1) | SE0103795D0 (enExample) |
| WO (1) | WO2003037889A1 (enExample) |
| ZA (1) | ZA200403206B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200508221A (en) | 2003-06-13 | 2005-03-01 | Astrazeneca Ab | New azetidine compounds |
| DE102004001873A1 (de) * | 2004-01-14 | 2005-09-29 | Bayer Healthcare Ag | Cyanopyrimidinone |
| WO2006121389A1 (en) * | 2005-05-10 | 2006-11-16 | Astrazeneca Ab | Use of a neurokinin-2 receptor antagonist for treating or preventing detrusor overactivity |
| AR057828A1 (es) | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
| US8106208B2 (en) | 2006-05-18 | 2012-01-31 | Albireo Ab | Benzamide compounds that act as NK receptor antagonists |
| TWI404721B (zh) | 2009-01-26 | 2013-08-11 | Pfizer | 胺基－雜環化合物 |
| CN112915266B (zh) * | 2021-02-05 | 2021-11-09 | 武汉磁济科技有限公司 | 一种人工膀胱铁磁复合体及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321557D0 (en) * | 1992-11-03 | 1993-12-08 | Zeneca Ltd | Carboxamide derivatives |
| GB9310713D0 (en) | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
| GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
| GB9322643D0 (en) * | 1993-11-03 | 1993-12-22 | Zeneca Ltd | Lactam derivatives |
| GB9421709D0 (en) * | 1994-10-27 | 1994-12-14 | Zeneca Ltd | Therapeutic compounds |
| US6008223A (en) * | 1994-10-27 | 1999-12-28 | Zeneca Limited | Therapeutic compounds |
| GB9505084D0 (en) * | 1995-03-14 | 1995-05-03 | Pfizer Ltd | Benzamide derivative |
| GB9922519D0 (en) | 1998-10-07 | 1999-11-24 | Zeneca Ltd | Compounds |
| GB9924141D0 (en) * | 1998-10-30 | 1999-12-15 | Zeneca Ltd | Treatment of gastric asthma |
| EP1136472A4 (en) * | 1998-12-04 | 2002-08-07 | Viromax L L C | ARYL- AND HETEROARYLAMIDES OF CARBOALCOXYSULFANILIC ACIDS |
| GB9826941D0 (en) | 1998-12-09 | 1999-02-03 | Zeneca Pharmaceuticals | Compounds |
| GB0015246D0 (en) * | 2000-06-22 | 2000-08-16 | Astrazeneca Ab | Method for the treatment of urinary incontinence |
-
2001
- 2001-11-02 SE SE0103795A patent/SE0103795D0/xx unknown
-
2002
- 2002-11-01 IL IL16160002A patent/IL161600A0/xx unknown
- 2002-11-01 DE DE60218203T patent/DE60218203T2/de not_active Expired - Fee Related
- 2002-11-01 CA CA002465429A patent/CA2465429A1/en not_active Abandoned
- 2002-11-01 MX MXPA04004075A patent/MXPA04004075A/es unknown
- 2002-11-01 EP EP02783904A patent/EP1444220B1/en not_active Expired - Lifetime
- 2002-11-01 US US10/494,195 patent/US7368461B2/en not_active Expired - Fee Related
- 2002-11-01 KR KR10-2004-7006520A patent/KR20040053239A/ko not_active Withdrawn
- 2002-11-01 BR BR0213832-8A patent/BR0213832A/pt not_active IP Right Cessation
- 2002-11-01 WO PCT/SE2002/001991 patent/WO2003037889A1/en not_active Ceased
- 2002-11-01 JP JP2003540170A patent/JP2005511571A/ja active Pending
- 2002-11-01 CN CNA028265696A patent/CN1610676A/zh active Pending
- 2002-11-01 AT AT02783904T patent/ATE353886T1/de not_active IP Right Cessation
- 2002-11-01 ES ES02783904T patent/ES2282491T3/es not_active Expired - Lifetime
-
2004
- 2004-04-28 ZA ZA200403206A patent/ZA200403206B/en unknown
- 2004-05-25 NO NO20042138A patent/NO20042138L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU711212B2 (en) | Methods for treating allergic disorders using (-) cetirizine | |
| JP4938905B2 (ja) | 選択的ｓ１ｐ１レセプターアゴニストの投与法 | |
| US6436938B1 (en) | Combination treatment for depression | |
| TW401297B (en) | Treatment and prophylaxis of osteoporosis | |
| JP2008521827A5 (enExample) | ||
| US20050182089A1 (en) | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist | |
| EP1358177B1 (en) | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance | |
| JP2002511425A (ja) | ロイコトリエン阻害剤と共にセチリジンを用いる、ロイコトリエン阻害に応答性の症状を治療するための方法および組成物 | |
| JP2006503850A5 (enExample) | ||
| JP5362151B2 (ja) | Ｐｇｄ２拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬 | |
| JP2005532397A5 (enExample) | ||
| JP5941258B2 (ja) | 他の薬剤と組合せた（ｒ，ｒ）−ホルモテロール | |
| WO1994006430A1 (en) | Methods and compositions for treating allergic disorders using optically pure (+) cetirizine | |
| JP2005511571A5 (enExample) | ||
| CN1172669C (zh) | 沙利度坦在制造治疗或预防主要抑郁性病症的药物中的应用 | |
| JP5386478B2 (ja) | パーキンソン病に伴う運動不全の治療のための４−シクロプロピルメトキシ−ｎ−（３，５−ジクロロ−１−オキシドピリジン−４−イル）−５−（メトキシ）ピリジン−２−カルボキサミドの使用 | |
| JP2005511561A5 (enExample) | ||
| JPH02138123A (ja) | 心不全治療用医薬組成物 | |
| JP2849796B2 (ja) | 強心剤 | |
| AU703690B2 (en) | Methods for treating allergic disorders using optically pure (+)cetirizine | |
| JPH0653678B2 (ja) | アレルギ−性疾患治療剤 | |
| JPH10101564A (ja) | 鼻炎予防及び／又は治療剤 | |
| WO2005041969A1 (en) | Pharmaceutical product comprising a beta-2 adrenergic agonist and an h1-receptor antagonist | |
| JP2006160639A5 (enExample) | ||
| JPH10109936A (ja) | 糖尿病性神経障害の治療・予防剤 |